Patent delisted for Circassia drug TUDORZA PRESSAIR

Copyright © DrugPatentWatch. Originally published at

Annual Drug Patent Expirations for TUDORZA+PRESSAIR
Tudorza Pressair is a drug marketed by Circassia and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.

This drug has one hundred and thirty-one patent family members in forty-four countries.

The generic ingredient in TUDORZA PRESSAIR is aclidinium bromide. One supplier is listed for this compound. Additional details are available on the aclidinium bromide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact or visit

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top